These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 17936557)
41. Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis. Moses MA; George AL; Sakakibara N; Mahmood K; Ponnamperuma RM; King KE; Weinberg WC Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340447 [TBL] [Abstract][Full Text] [Related]
42. Mesodermal deletion of transforming growth factor-beta receptor II disrupts lung epithelial morphogenesis: cross-talk between TGF-beta and Sonic hedgehog pathways. Li M; Li C; Liu YH; Xing Y; Hu L; Borok Z; Kwong KY; Minoo P J Biol Chem; 2008 Dec; 283(52):36257-64. PubMed ID: 18990706 [TBL] [Abstract][Full Text] [Related]
43. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis. Guo Y; Kyprianou N Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572 [TBL] [Abstract][Full Text] [Related]
44. Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling. Schober M; Fuchs E Proc Natl Acad Sci U S A; 2011 Jun; 108(26):10544-9. PubMed ID: 21670270 [TBL] [Abstract][Full Text] [Related]
45. Menin expression is regulated by transforming growth factor beta signaling in leukemia cells. Zhang H; Liu ZG; Hua XX Chin Med J (Engl); 2011 May; 124(10):1556-62. PubMed ID: 21740816 [TBL] [Abstract][Full Text] [Related]
46. TGFBR1 and cancer susceptibility. Pasche B; Pennison MJ; Jimenez H; Wang M Trans Am Clin Climatol Assoc; 2014; 125():300-12. PubMed ID: 25125747 [TBL] [Abstract][Full Text] [Related]
47. Modeling the transcriptional consequences of epidermal growth factor receptor ablation in Ras-initiated squamous cancer. Wright LN; Ryscavage A; Merlino G; Yuspa SH Clin Cancer Res; 2012 Jan; 18(1):170-83. PubMed ID: 22068661 [TBL] [Abstract][Full Text] [Related]
48. Solar ultraviolet irradiation reduces collagen in photoaged human skin by blocking transforming growth factor-beta type II receptor/Smad signaling. Quan T; He T; Kang S; Voorhees JJ; Fisher GJ Am J Pathol; 2004 Sep; 165(3):741-51. PubMed ID: 15331399 [TBL] [Abstract][Full Text] [Related]
50. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III. Deng X; Bellis S; Yan Z; Friedman E Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213 [TBL] [Abstract][Full Text] [Related]
51. Defects in transforming growth factor-beta signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes. Glick A; Popescu N; Alexander V; Ueno H; Bottinger E; Yuspa SH Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14949-54. PubMed ID: 10611318 [TBL] [Abstract][Full Text] [Related]
52. Overexpression of a dominant-negative type II TGFbeta receptor tagged with green fluorescent protein inhibits the effects of TGFbeta on cell growth and gene expression of mouse adrenal tumor cell line Y-1 and enhances cell tumorigenicity. Le Roy C; Maisnier-Patin K; Leduque P; Li JY; Saez JM; Langlois D Mol Cell Endocrinol; 1999 Dec; 158(1-2):87-98. PubMed ID: 10630409 [TBL] [Abstract][Full Text] [Related]
53. The role of Sp1 in the differential expression of transforming growth factor-beta receptor type II in human breast adenocarcinoma MCF-7 cells. Liu Y; Zhong X; Li W; Brattain MG; Banerji SS J Biol Chem; 2000 Apr; 275(16):12231-6. PubMed ID: 10766860 [TBL] [Abstract][Full Text] [Related]
54. Regulated intramembrane proteolysis of the TGFβ type I receptor conveys oncogenic signals. Gudey SK; Wallenius A; Landström M Future Oncol; 2014 Aug; 10(11):1853-61. PubMed ID: 24597658 [TBL] [Abstract][Full Text] [Related]
55. Quantitative analysis of the secretome of TGF-beta signaling-deficient mammary fibroblasts. Xu BJ; Yan W; Jovanovic B; An AQ; Cheng N; Aakre ME; Yi Y; Eng J; Link AJ; Moses HL Proteomics; 2010 Jul; 10(13):2458-70. PubMed ID: 20405477 [TBL] [Abstract][Full Text] [Related]
56. Novel permissive role of epidermal growth factor in transforming growth factor beta (TGF-beta) signaling and growth suppression. Mediation by stabilization of TGF-beta receptor type II. Song K; Krebs TL; Danielpour D J Biol Chem; 2006 Mar; 281(12):7765-74. PubMed ID: 16428382 [TBL] [Abstract][Full Text] [Related]
57. C/EBPβ deletion in oncogenic Ras skin tumors is a synthetic lethal event. Messenger ZJ; Hall JR; Jima DD; House JS; Tam HW; Tokarz DA; Smart RC Cell Death Dis; 2018 Oct; 9(11):1054. PubMed ID: 30323292 [TBL] [Abstract][Full Text] [Related]
58. A novel TGF-β receptor II mutation (I227T/N236D) promotes aggressive phenotype of oral squamous cell carcinoma via enhanced EGFR signaling. Son HK; Kim D; Lim Y; Kim J; Park I BMC Cancer; 2020 Nov; 20(1):1163. PubMed ID: 33246423 [TBL] [Abstract][Full Text] [Related]
59. Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer. Takahashi K; Akatsu Y; Podyma-Inoue KA; Matsumoto T; Takahashi H; Yoshimatsu Y; Koinuma D; Shirouzu M; Miyazono K; Watabe T J Biol Chem; 2020 Sep; 295(36):12559-12572. PubMed ID: 32631954 [TBL] [Abstract][Full Text] [Related]
60. Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis. Vitale-Cross L; Amornphimoltham P; Fisher G; Molinolo AA; Gutkind JS Cancer Res; 2004 Dec; 64(24):8804-7. PubMed ID: 15604235 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]